| Literature DB >> 25167470 |
Bit Lee1, Halesha D Basavarajappa, Rania S Sulaiman, Xiang Fei, Seung-Yong Seo, Timothy W Corson.
Abstract
An antiangiogenic homoisoflavanone, cremastranone, was synthesized for the first time. This scalable synthesis, which includes selective demethylation, could be used to develop lead molecules to treat angiogenesis-induced eye diseases. Synthetic cremastranone inhibited the proliferation, migration and tube formation ability of human retinal microvascular endothelial cells, important steps in pathological angiogenesis.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25167470 PMCID: PMC4167916 DOI: 10.1039/c4ob01604a
Source DB: PubMed Journal: Org Biomol Chem ISSN: 1477-0520 Impact factor: 3.876